Medical Research
Cholangiocarcinoma Foundation
SALT LAKE CITY, UT
Total revenue
$6.9M
Total expenses
$6.2M
Net assets
$4.5M
Grants received
$4.8M
180 grants
EIN
205776861
Tax year
2023
Mission
The organization's mission is to find a cure and improve the quality of life for cholangiocarcinoma patients.
Programs
1 program
Patient support the organization operates globally with the mission of finding a cure for cholangiocarcinoma (bile duct cancer)and improving the quality of life for patients. It pursues innovative methodologies, technologies, and partnerships to drive education, support programs, research, and funding strategies. The foundation supports patients and their caregivers by connecting them to resources, mentors, support groups, and informational webinars. The organization provides information to equip patients and their caregivers to navigate their treatment journey alongside their healthcare providers.
Financials
FY 2023
Revenue
Expenses
People
14 listed
STACIE LINDSEY
CEO/FOUNDER
$202K
40 hrs/wk
ALLI WARD
COO
$153K
40 hrs/wk
TERESA DELCORSO-ELLMANN
CHAIR
—
5 hrs/wk
PATRICIA MAXIN
SECRETARY
—
2.5 hrs/wk
DANIEL BLUM
TREASURER
—
2.5 hrs/wk
DEAN MEYER
BOARD MEMBER
—
5 hrs/wk
ROSS GREEN
BOARD MEMBER
—
2.5 hrs/wk
JASON SCOTT
BOARD MEMBER
—
2.5 hrs/wk
JACK CALLAWAY
BOARD MEMBER
—
2.5 hrs/wk
LIZ WARNER
BOARD MEMBER
—
2.5 hrs/wk
TYLER BRIDEGAN
BOARD MEMBER
—
2.5 hrs/wk
COLLEEN MATHER
BOARD MEMBER
—
2.5 hrs/wk
KOURTNEY SANCHEZ
CDO
$150K
40 hrs/wk
MELINDA BACHINI
CPO
$103K
40 hrs/wk
Independent contractors
SODEXO
CATERING
ENCORE
AUDIO VISUAL
KOMODO HEALTH INC
ANALYTICS
Grants received
Showing 180 of 180
Funded by
$4.8M from 82 funders · 180 grants · 2017–2024
$1.6M · 8 grants · 2017–2023
$765K · 3 grants · 2022–2024
$635K · 5 grants · 2019–2024
$333K · 4 grants · 2020–2023
$275K · 5 grants · 2020–2024
$227K · 4 grants · 2020–2023
$205K · 6 grants · 2019–2024
$150K · 1 grant · 2023